Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. [electronic resource]
Producer: 20070605Description: 3676-8 p. digitalISSN:- 0006-4971
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Benzamides
- Disease-Free Survival
- Female
- Follow-Up Studies
- Fusion Proteins, bcr-abl -- genetics
- Humans
- Imatinib Mesylate
- Male
- Middle Aged
- Piperazines -- administration & dosage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Pyrimidines -- administration & dosage
- Remission Induction
- Steroids -- administration & dosage
- Survival Rate
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.